banter and General Discussion, page-8800

Actually, the FDA routinely monitors sponsor communications, including social media. They will quickly and forcefully inform the sponsor if they step over the line - but there is no real onus on the company to then inform the market (on the basis they would likely assess it as not being material). Any such transgressions will however make future relationships with the FDA extremely fraught.

While the announcements around FDA matters are likely true (the consequences of actively lying to the ASX are enough to deter most directors from even contemplating it), the question is whether it is the whole truth rather than a selective reading. Having said that, of course it will always be selective to some extent, short of publishing every single communication between the sponsor and the FDA - however, I remain to be convinced that all relevant aspects have been disclosed based on my interactions with the FDA and their typical CRL responses over many years.